Skip to content

Clinical trials

Completed Lung Diseases, Interstitial trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Not applicable Status: Completed Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20101
20112
20123
20134
20144
20153
20165
20174
20182
20194
20207
20215
20225
20236
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University3
Johns Hopkins University3
Schön Klinik Berchtesgadener Land3
Aveiro University2
Cairo University2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2
Gazi University2
University Hospital, Montpellier2
University of Manitoba2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial63
Pulmonary Disease, Chronic Obstructive18
Idiopathic Pulmonary Fibrosis9
Pulmonary Fibrosis7
Dyspnea6
Heart Failure6
Asthma4
Kidney Failure, Chronic4
Lung Diseases4
Neoplasms4

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.